The Faculty of Medicine is offering generous scholarships to students with outstanding academic potential who apply in 2014 for one of the 30 Master’s courses run by its Schools, Institutes and Departments.
There are 4 Dean’s Master’s Scholarships available (full fees plus £17.5K flexible stipend), 2 for Home/EU and 2 for Overseas students, and 10 Faculty Master’s Scholarships (£17.5K flexible stipend), open to both Home/EU and overseas students. Application is via an online form and the deadline is 31 March 2014.
Please advertise these widely to attract the best students to our courses. Posters such as those below (plus more styles) are available for download. These can be printed for display in your location and/or sent via e-mail to prospective applicants or contacts in other universities (and overseas) who would be willing to circulate the information to their life science/medicine undergraduates.
If you have any queries about the Scholarships or Master’s courses, please contact Jim Osborne
Imperial College has figured at No 4 globally in the Times Higher Education (THE) World University rankings in the Category of Clinical, Pre-Clinical and Health, a rise of one place since 2012. This is excellent news and reflects strongly on the quality of our faculty and on the sustained excellence of the research and teaching at Imperial College. So thanks to all of you for helping to deliver this remarkable achievement which clearly reflects an extraordinary body of work. Every small contribution helps – from taking extra time over a worried student to discovery of a new pathway relevant to human disease or in translating research into policy. The ability to translate does appear to be an important theme in this category with important implications in enhancing reputation. We have a wonderful research eco-system in the Faculty of Medicine that enables us to convert our discoveries into real benefits for patients through our partnerships in the AHSC and the AHSN.
This theme of translation is also followed through in the Life Sciences table with Harvard ranked at No 1. The Citation in THE interestingly cites Harvard’s ability to accelerate the pathway from discovery to product through the Harvard Biomedical Accelerator Fund and the capacity to rapidly move from test-tube to clinic as a key factor in its success. As we look to the future with development of Imperial West looming on the horizon, there may be important pointers for us here in terms of our translational strategy. How we develop strategically with our international partners may be key to moving further ahead in the University rankings in the future.